News
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
21+ hour, 7+ min ago (271+ words) In the prospective, multicenter study, investigators at 20 sites across the U.S. enrolled 318 patients taking glaucoma medications. Patients were previously diagnosed with mild to moderate primary open-angle glaucoma as well as cataracts. Two co-primary effectiveness endpoints were evaluated: the percentage of patients…...
Peptides are booming in the fitness world. Here’s what you should know about the risks
1+ day, 5+ hour ago (687+ words) Longevity influencers and biohackers often tout peptides as a miracle cure for fat loss, muscle building and better sleep. There are peptides for skin care, inflammation and cognitive improvement. You can buy peptides promising improved energy, hormone regulation, or even…...
Smartwatches show promise in identifying increased risk of heart failure hospitalization
3+ day, 3+ hour ago (53+ words) Smartwatches show promise in identifying increased risk of heart failure hospitalization'The Globe and Mail Smartwatches show promise in identifying increased risk of heart failure hospitalization In a Nature Medicine study led by UHN's Peter Munk Cardiac Centre, researchers evaluated large-scale…...
Cintas Location in Midland Certified as MVPP Star Worksite
3+ day, 3+ hour ago (162+ words) The Michigan Occupational Safety and Health Administration (MIOSHA) formally honored Cintas Corporation's (Nasdaq: CTAS) site in Midland, Michigan, as an MVPP Star Worksite-certified location. During the award presentation, Todd Mengeu, the Midland location's General Manager, accepted the honor on behalf…...
Mothers of autistic children in Ontario earn significantly less than fathers, study finds
2+ day, 14+ hour ago (1066+ words) Dr. Janet McLaughlin, associate professor of health studies at Wilfrid Laurier, encourages her autistic son Sebastian to strum on the guitar while singing at their Waterloo home.Alicia Wynter/The Globe and Mail Mothers of autistic children in Ontario are…...
OCGN Gene Therapy Pipeline: 2026-2027 Catalysts To Watch
3+ day, 7+ hour ago (601+ words) Ocugen'OCGN is pushing three retinal gene therapy programs toward late-stage milestones, with multiple data readouts and regulatory steps clustered into 2026 and early 2027. The setup makes the next several quarters especially event-driven. For investors, the key is how cleanly timelines hold....
Ontario to miss deadline to fund nurse practitioners, leaving some patients paying out of pocket
3+ day, 9+ hour ago (990+ words) Ontario will not have a policy in place to publicly fund all medically necessary services from nurse practitioners by April 1, as ordered by the federal government, leaving some patients paying out of pocket for primary care. Health Minister Sylvia Jones…...
Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation
5+ day, 5+ hour ago (160+ words) Dosing of first patient initiates Phase 1 clinical evaluation of BMS-986506 for the treatment of advanced clear cell renal cell carcinoma, the most common form of kidney cancer Transformative moment in strategic protein degradation collaboration with Bristol Myers Squibb (BMS) aiming…...
Ontario to create electronic medical record system to streamline patient data sharing
4+ day, 1+ hour ago (674+ words) Ontario Health Minister Sylvia Jones at Queen's Park in Toronto in October, 2025. Ms. Jones unveiled the primary care electronic medical record plan on Thursday.Laura Proctor/The Canadian Press The Ontario government is promising to create a centralized electronic medical…...
Castle Biosciences to Present Data at SSO 2026 on DecisionDx®-Melanoma’s i31-SLNB, Identifying T1b–T2a Melanoma Patients Who May Safely Avoid SLNB
2+ week, 4+ day ago (128+ words) Castle will share the following ePoster at SSO: EP49: The integrated 31-gene expression profile test identifies patients with T1b'T2a cutaneous melanoma who can safely avoid sentinel lymph node biopsy. ePosters will be available for viewing in the SSO 2026 Exhibit Hall, on the…...